Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
112.22
+6.96 (6.61%)
May 5, 2026, 1:17 PM EDT - Market open
Veradermics Market Cap
Veradermics has a market cap or net worth of $4.19 billion as of May 5, 2026.
Market Cap
4.19B
Enterprise Value
4.05B
1-Year Change
n/a
Ranking
Category
Stock Price
$112.22
Market Cap Chart
Since the IPO on February 4, 2026, Veradermics's market cap has increased from $1.32B to $4.19B, an increase of 216.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 3.93B | 4.22% |
| May 1, 2026 | 3.77B | 2.02% |
| Apr 30, 2026 | 3.70B | -7.09% |
| Apr 29, 2026 | 3.98B | 3.35% |
| Apr 28, 2026 | 3.85B | 3.00% |
| Apr 27, 2026 | 3.74B | 47.55% |
| Apr 24, 2026 | 2.53B | -2.04% |
| Apr 23, 2026 | 2.59B | -1.51% |
| Apr 22, 2026 | 2.63B | -4.14% |
| Apr 21, 2026 | 2.74B | -0.84% |
| Apr 20, 2026 | 2.76B | -3.04% |
| Apr 17, 2026 | 2.85B | 2.93% |
| Apr 16, 2026 | 2.77B | -7.93% |
| Apr 15, 2026 | 3.01B | 7.35% |
| Apr 14, 2026 | 2.80B | 5.09% |
| Apr 13, 2026 | 2.66B | 3.72% |
| Apr 10, 2026 | 2.57B | 14.70% |
| Apr 9, 2026 | 2.24B | 3.34% |
| Apr 8, 2026 | 2.17B | 2.35% |
| Apr 7, 2026 | 2.12B | -11.14% |
| Apr 6, 2026 | 2.38B | -0.58% |
| Apr 2, 2026 | 2.40B | 9.20% |
| Apr 1, 2026 | 2.19B | -6.92% |
| Mar 31, 2026 | 2.36B | 3.78% |
| Mar 30, 2026 | 2.27B | -7.14% |
| Mar 27, 2026 | 2.45B | -2.99% |
| Mar 26, 2026 | 2.52B | 3.04% |
| Mar 25, 2026 | 2.45B | 3.26% |
| Mar 24, 2026 | 2.37B | 2.54% |
| Mar 23, 2026 | 2.31B | 5.15% |
| Mar 20, 2026 | 2.20B | 3.48% |
| Mar 19, 2026 | 2.12B | -3.56% |
| Mar 18, 2026 | 2.20B | -3.37% |
| Mar 17, 2026 | 2.28B | 7.23% |
| Mar 16, 2026 | 2.13B | 7.86% |
| Mar 13, 2026 | 1.97B | 2.39% |
| Mar 12, 2026 | 1.93B | 1.06% |
| Mar 11, 2026 | 1.91B | 0.75% |
| Mar 10, 2026 | 1.89B | -1.31% |
| Mar 9, 2026 | 1.92B | 5.68% |
| Mar 6, 2026 | 1.81B | -0.12% |
| Mar 5, 2026 | 1.82B | 2.68% |
| Mar 4, 2026 | 1.77B | 5.04% |
| Mar 3, 2026 | 1.68B | -3.30% |
| Mar 2, 2026 | 1.74B | 1.68% |
| Feb 27, 2026 | 1.71B | 6.85% |
| Feb 26, 2026 | 1.60B | 1.75% |
| Feb 25, 2026 | 1.57B | -3.70% |
| Feb 24, 2026 | 1.64B | -2.69% |
| Feb 23, 2026 | 1.68B | 1.15% |
| Feb 20, 2026 | 1.66B | -7.93% |
| Feb 19, 2026 | 1.80B | -3.51% |
| Feb 18, 2026 | 1.87B | 5.70% |
| Feb 17, 2026 | 1.77B | 9.02% |
| Feb 13, 2026 | 1.62B | -2.21% |
| Feb 12, 2026 | 1.66B | 0.91% |
| Feb 11, 2026 | 1.64B | 8.88% |
| Feb 10, 2026 | 1.51B | 9.24% |
| Feb 9, 2026 | 1.38B | -3.77% |
| Feb 6, 2026 | 1.44B | 3.55% |
| Feb 5, 2026 | 1.39B | 4.78% |
| Feb 4, 2026 | 1.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.30B |
| Travere Therapeutics | 4.12B |
| Oruka Therapeutics | 3.83B |
| Telix Pharmaceuticals | 3.82B |
| ACADIA Pharmaceuticals | 3.73B |
| Viking Therapeutics | 3.72B |
| Catalyst Pharmaceuticals | 3.53B |
| NewAmsterdam Pharma Company | 3.36B |